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Abstract
Background: Accumulating evidences indicated that lncRNAs play crucial regulatory roles in oncogenesis and
progression of cancers. BRAF activated non-coding RNA (BANCR) has been identified to contribute to the
progression of some human cancers. However, the relationship between BANCR and bladder cancer (BC) is largely
unclear.
Methods: BANCR expression levels in BC, paired non-cancer tissues and BC cell lines were detected by real-time
quantitative RT-PCR (qRT-PCR). The relationships between BANCR expression levels and the clinical characteristics
were evaluated. BANCR expression was enhanced by transfecting a pcDNA-BANCR vector. We used both CCK-8
assay and Edu assay to detect cell proliferation. We also detect cell apoptosis and migration by using ELISA assay,
Flow cytometry and transwell assay, respectively. All statistical analyses were executed by using the SPSS 20.0
software.
Results: BANCR expression levels were remarkably decreased in BC tissues compared with adjacent noncancerous
tissues. BANCR expression levels in two BC cell lines were also significantly down-regulated. Clinicopathologic
analysis revealed that low BANCR expression was positively correlated with TNM stage, but not associated with
other clinicopathological characteristics. BANCR has been successfully overexpressed in BC cell lines (T24 and
SW780) by transfecting a pcDNA-BANCR vector. Cell proliferation inhibition, apoptosis induction and migration
suppression were also observed in pCDNA-BANCR-transfected T24 and SW780 cells.
Conclusions: These data suggested that BANCR represents a tumor suppressor player in bladder cancer,
contributes to tumor proliferation, apoptosis and migration, and may serve as a new candidate biomarker and a
potential therapeutic target for patients with BC.
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Background
Bladder cancer (BC) is one of the most common malig-
nancies over the world, and its incidence and mortality
have captured great attention in the past decades [1, 2].
Although a variety of treatments are available for patients
with bladder cancer, such as surgery, chemotherapy and
radiation therapy, but the 5-year cancer-specific survival
rate remains frustrated [3–5]. Lack of sophisticated under-
standing of pathogenetic mechanism is one of the most
crucial reasons for high case fatality rate of bladder cancer.
So, revealing the pathogenetic mechanism of bladder can-
cer is indispensable for developing an effective diagnosis
or treatment.
With the rapid development of second-generation se-
quencing technology, a multitude of long noncoding
RNAs (lncRNAs) have been found to be dysregulated
and involved in the development of various human
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diseases, particularly in cancers [6–8]. Accumulating
evidences demonstrated that lncRNAs play important
regulatory roles in diverse cellular processes, such as
regulation of gene expression, posttranslational process-
ing and tumorigenesis [7, 9]. BRAF activated non-coding
RNA (BANCR), a 693-nt lncRNA encoded on human
chromosome 9, has been found to be aberrant expressed
in quite a few cancers, such as colorectal cancer [10],
retinoblastoma [11], melanoma [12], papillary thyroid
carcinoma [13], lung carcinoma [14],gastric cancer [15]
and hepatocellular carcinoma [16]. However, the signifi-
cance of lncRNA BANCR in bladder cancer is com-
pletely unknown.
Thus, in the present research, we identified the clinical
significance of lncRNA BANCR in 54 clinical bladder
cancer samples and investigated the effects of BANCR
expression on bladder cancer cells in vitro. Moreover,
further experiments indicated that the overexpression of
lncRNA BANCR could inhibit proliferation, induce




In this research, a total of 54 patients with urothelial
neoplasms of the bladder who received radical cystec-
tomy were included. Bladder cancer tissues and their
pair-matched adjacent normal tissues were snap-frozen
in liquid nitrogen quickly after resection.
Cell lines and cell culture
Human bladder cancer cell lines (T24, SW780) and SV-
40-immortalized human uroepithelial cell line (SV-HUC-
1) were purchased from the Institute of Cell Biology,
Chinese Academy of Sciences (Shanghai, China). The T24
and SW780 cells were cultured in Dulbecco’s Modified
Eagle Medium (Invitrogen, Carlsbad, CA, USA) plus 1 %
antibiotics (100U/ml penicillin and100 μg/ml strepto-
mycin sulfates) and 10 % fetal bovine serum (FBS). The
SV-HUC-1 cells were cultured in F12K (Invitrogen, Carls-
bad, CA, USA) plus 1 % antibiotics (100U/ml penicillin
and100 μg/ml streptomycin sulfates) and 10 % fetal bovine
serum (FBS). All cells were cultured at 37 °C, in a humidi-
fied atmosphere with 5 % CO2.
Plasmid DNA Transfection
The BANCR sequence and negative control were synthe-
sized and subcloned into pCDNA3.1 (GenePharma,
Suzhou, China) vector. The pCDNA-BANCR or negative
control was transfected into T24 and SW780 cells cultured
in six-well plates using Lipofectamine 3000 Transfection
Reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s protocol. The expression level of BANCR
was detected by qRT-PCR.
RNA extraction and qRT-PCR
All total RNA was extracted from bladder cancer tissues
or cells after transfection by using the Trizol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer’s protocol. Qualified total RNA was then reverse
transcribed to cDNA by utilizing Prime Script RT Re-
agent Kit with gDNA Eraser (Takara, Dalian, China) fol-
lowing the manufacturer’s instructions. The quantitative
real-time polymerase chain reaction (qRT-PCR) was exe-
cuted using SYBR Green PCR kit (Takara, Dalian, China)
following the manufacturer’s instructions. Glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) was mea-
sured as an internal control. The primer sequences were
as follows: BANCR primers: 5’- ACAGGACTCCATGG
CAAACG-3’ (forward) and 5’- ATGAAGAAAGCCTG
GTGCAGT-3’ (reverse), and GAPDH primers: 5’-CGC
TCTCTGCTCCTCCTGTTC-3’ (forward), 5’–ATCC
GTTGACTCCGACCTTCAC-3’ (reverse). The reactions
were carried out on an ABI PRISM 7300 Fluorescent
Quantitative PCR System (Applied Biosystems, Foster
City, CA, USA) in triplicate. The average value in each
triplicate was used to calculate the relative amount of
BANCR using 2−ΔΔCt methods.
Cell proliferation assays
Cell proliferation was determined by using Cell
Counting Kit-8, CCK-8 (Beyotime Institute of Biotech-
nology, Shanghai, China) and 5-ethynyl-20-deoxyuri-
dine (Edu) assay kit (Ribobio, Guangzhou, China),
respectively, according to the manufacturer’s instruc-
tions. For CCK-8 assay, 5 × 103cells/ well were seeded
in a 96-well plate for 24 h, then transiently transfected
with pCDNA-BANCR or negative control. CCK-8
assay was performed according to the previous study.
Edu incorporation assay was carried out according to
previous studies [17]. All experiments were performed
at least three times.
Caspase-3 ELISA assay
Bladder cancer cells T24 and SW780 were transfected
with pCDNA-BANCR or negative control. At 48 h
after transfection, the activity of caspase 3 was de-
tected by using the Caspase-3 Colorimetric Assay kit
(Abcam, Cambridge, UK) according to the manufac-
turer’s protocol. Each experiment was performed in
triplicate.
Flow cytometry assay
T24 and SW780 cells were transfected with pCDNA-
BANCR or negative control in normal medium. After
48 h, cells were harvested for flow cytometry assay.
After double staining with FITC-Annexin V and PI
according to the manufacturer’s instructions, cell
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apoptosis was determined by using flow cytometry
(EPICS, XL-4, Beckman, CA, USA).
Transwell assay
The cell motility assay were performed using a transwell in-
sert (8 μm, Corning). After 24 h, 5x104 cells transfected
with pCDNA-BANCR or negative control were first starved
in 200 ml serumfree medium and then placed in the un-
coated dishes. Transwell assay was performed according to
one previous study [18].
Statistical analyses
All statistical analyses were executed by using SPSS
20.0 software (IBM, Chicago, IL, USA). Paired samples’t
test was used to analyze the BANCR expression differ-
ence between bladder cancer tissues and para-cancer
tissues. CCK-8 assay data were analyzed by ANOVA
and independent samples’ t test was utilized to analyze
other data. The chi-square test was used to exam the
relationship between BANCR expression level and clin-
icopathologic characteristics. Differences were consid-
ered statistically significant at p < 0.05.
Fig. 1 The long noncoding RNA BANCR was down-regulated in bladder cancer. The relative expression levels of BANCR were determined using
RT- qPCR. a BANCR expression levels were lower in bladder cancer tissues. b The relative expression level of BANCR was significantly lower in
bladder cancer tissues compared with pair-matched adjacent normal bladder tissues. c BANCR expression levels were dramatically lower in patients with
higher TNM stage. d BANCR expression levels were lower in bladder cancer T24 and SW780 cells than those in SV-40-immortalized human uroepithelial
cells. e The pCDNA-BANCR significantly up-regulated the expression level of BANCR in SW780 and T24 cells. Data (b and c) are shown as mean ± SEM.
Data (d and e) are shown as mean ± SD. (**P< 0.01, ***P< 0.001)
Table 1 Correlation between BANCR expression and
clinicopathological characteristics of bladder cancer patients




Gender Male 38 16 22 0.09
Female 16 3 13
Age(years) <65 29 12 17 0.230
≥65 25 7 18
Tumor size (cm) <3 24 11 13 0.065
≥3 30 8 22
Histological grade L 20 9 11 0.194
H 34 10 24
TNM stage 0/ I 15 10 5 0.004*
II/III/IV 39 9 30
Lymph nodes metastasis N0 50 18 32 0.559
N1 or above 4 1 3
*P < 0.05 was considered significant (Chi-square test between 2 groups)
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Results
BANCR was down-regulated in bladder cancer tissues and
cells
The relative expression level of BANCR was measured by
using qRT-PCR in bladder cancer tissues and pair-matched
adjacent normal bladder tissues from 54 bladder cancer
patients. Compared with pair-matched adjacent normal
bladder tissues, the BANCR expression was down-
regulated significantly in 64.8 % (35 of 54) of cancer tissues
(Fig. 1a and b, ***P < 0.001). Moreover, down-regulated
BANCR expression was significantly correlated with ad-
vanced TNM stage (Fig. 1c, **P < 0.01). Compared with the
SV-HUC-1 cell line, the BANCR expression was decreased
significantly in bladder cancer cellsT24 and SW780 (Fig. 1d,
**P < 0.01). These data demonstrated that BANCR may
function as a tumor suppressor gene in bladder cancer. Pa-
tients’ clinical parameters are listed in Table 1.
Specific plasmid vectors up-regulated the expression of
BANCR
Bladder cancer cell lines T24 and SW780 were cultured
and transfected with pCDNA-BANCR or negative control.
At 48 h after transfection, the related expression level of
BANCR was analyzed by qRT-PCR and the results showed
Fig. 2 Overexpression of lncRNA BANCR inhibited cell proliferation in bladder cancer cells. Cell proliferation was detected by both CCK-8 assay
and Edu assay. Cell proliferation inhibition was observed in bladder cancer T24 (a, c and e), SW780 (b, d and f). Data are shown as mean ± SD.
(**P < 0.01, ***P < 0.001)
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that the relative expression level of BANCR in T24 and
SW780 (Fig. 1e, **P < 0.01) cells was significantly up-
regulated.
Overexpression of BANCR inhibited cell proliferation
To explore the possible impact of BANCR on the
growth of bladder cancer cells, the cell proliferation
activities of T24 and SW780 were determined by both
CCK-8 assay and Edu assay. Compared with the nega-
tive control group, cell growth arrest was observed in
bladder cancer cells T24 (Fig. 2a, c and e) and
SW780 (Fig. 2b, d and f ) which were cultured and
transfected with pCDNA-BANCR. The results sug-
gested that BANCR inhibits cell proliferation in blad-
der cancer cells.
Overexpression of BANCR induced apoptosis
Furthermore, we investigated whether BANCR could in-
duce cell apoptosis in bladder cancer. Bladder cancerT24
and SW780 cells were transfected with pCDNA-BANCR
or negative control. The relative activity of caspase-3
was determined using the caspase 3 enzyme-linked im-
munosorbent assay (ELISA) (Fig. 3a, d) and the apop-
tosis ratio in bladder cancer cells was measured using
flow cytometry assay. (Figure 3b, c, e and f). Induced cell
apoptosis was observed in both bladder cancer and
SW780 cell lines. These results indicated that BANCR
induces cell apoptosis in bladder cancer.
Overexpression of BANCR inhibited cell migration
Lastly, we further determined whether BANCR sup-
pressed cell migration in bladder cancer. The cell migra-
tion activities of bladder cancer T24 and SW780 cells
transfected with pCDNA-BANCR or negative control
were determined by transwell assay. Cell migration ar-
rest was observed in T24 (Fig. 4a, b), SW780 (Fig. 4c, d)
as expected. These results manifested that BANCR in-
hibits cell migration in bladder cancer.
Discussion
Until now, lots of works indicate that lncRNAs play vital
regulatory roles in tumorigenesis and tumor progression
and act as potential oncogenes or tumor suppressor genes
[19, 20]. Recently, several lncRNAs have been found to play
an emerging role in various cancers, contributing to tumor
proliferation, apoptosis, and survival, such as PANDAR
[18], MEG3 [21].
BANCR, firstly found by Flockhart RJ et al. [22], has
been discovered to be up-regulated in some kinds of tu-
mors, including retinoblastoma, melanoma, papillary
thyroid carcinoma, gastric cancer and hepatocellular car-
cinoma. In contrast, decreased expression of BANCR
Fig. 3 Overexpression of lncRNA BANCR induced cell apoptosis in bladder cancer cells. Cell apoptosis was determined by both ELISA assay and
Flow cytometry. Induced cell apoptosis was observed in bladder cancer T24 (a, b and c) and SE780 (d, e and f) cells. Data are shown as mean ±
SD. (**P < 0.01, ***P < 0.001)
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has been found in both colorectal and lung cancers.
BANCR promotes cell proliferation by regulating MAPK
pathway activation in both malignant melanoma and
lung carcinoma [14, 23]. Besides, downregulation of
BANCR promotes colorectal cancer cell proliferation
through decreasing expression of p21 protein [10]. Fur-
thermore, BANCR expression promoted non-small cell
lung cancer cell migration and invasion through regulat-
ing E-cadherin, N-cadherin and Vimentin expression, all
of which play crucial roles in epithelial-mesenchymal
transition (EMT) [24]. These evidences suggest that
BANCR may be involved in different signaling pathways
and plays its unique role in each cancer. However, the
functions of BANCR in bladder cancer were completely
unknown.
To the best of our knowledge, this is the first evidence
that BANCR was significantly downregulated in bladder
cancer tissues compared with adjacent noncancerous tis-
sues, and low BANCR expression in bladder cancer pa-
tients was positively correlated with advanced TNM stage.
Furthermore, compared with the SV-HUC-1 cell line, the
BANCR expression in bladder cancer cell lines (T24,
SW780) was also obviously downregulated. These results
manifest that lncRNA BANCR may emerge as a novel
player in bladder cancer. To further explore the biological
functions of lncRNA BANCR, we detected the cell prolifer-
ation, apoptosis and migration by overexpressing BANCR
in bladder cancer T24 and SW780 cells. pCDNA-BANCR-
mediated overexpression of BANCR significantly inhibited
proliferation, promoted apoptosis and suppressed metasta-
sis capabilities of bladder cancer T24 and SW780 cells
compared with control group, suggesting that up-regulated
BANCR expression could suppress the progression and de-
velopment of bladder cancer.
Conclusion
In conclusion, the present study suggested that lncRNA
BANCR was decreased in BC tissues and correlated with
advanced TNM stage. Moreover, we preliminarily re-
vealed the significant function of BANCR in regulating
cell proliferation, apoptosis, and migration of BC cells.
These findings indicated that BANCR may emerge as a
tumor suppressor gene and could become a novel prom-
ising candidate for the prognosis and therapy for BC in
the future. However, the prognostic role of BANCR
should be verified in a larger case series, composed by
firstly diagnosed patients, treated with TURB instead of
cystectomy and with a minimum of 3 years of follow up.
Moreover, the molecular mechanism by which BANCR
was decreased in bladder cancer also should be investi-
gated in the future works.
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